Structure-guided discovery of a dual JAK2/RAGE modulator reveals a computationally driven strategy for targeting convergent oncogenic signaling in renal cell carcinoma
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.